Mars, Digitalis Ventures launch US$300M venture capital fund, Companion Fund II, to support pet care startups leveraging advanced science, tech; fund to provide capital to range of enterprises developing vet diagnostics, medicine, IT and online platforms

Sample article from our Pet Care

MCLEAN, Virginia , October 13, 2023 (press release) –

  • Mars, Incorporated and Digitalis Ventures announce the launch of Companion Fund II
  • A $300 million dollar venture capital fund that will back companies leveraging breakthrough science, technology and design
  • The launch of the second fund confirms Mars’ ongoing commitment to support pet care innovators and its long-term partnership with Digitalis Ventures

Today Mars, Incorporated and Digitalis Ventures announced the launch of Companion Fund II, a $300 million dollar venture capital fund that will back founders whose companies are leveraging breakthrough science, technology and design to improve the lives of pets, pet owners and veterinarians. This second fund follows the first Companion Fund, a $100m fund launched in 2018.

Loïc Moutault, Global President Mars Petcare said: “Our goal is to support pet care founders accelerating the trajectory of startups, helping to fuel the growth of pet care businesses and to contribute to the future of the pet care industry. We're excited to support entrepreneurs and innovators in creating new products and services that deliver on our purpose: 'A Better World for Pets.'"

Companion Fund II will provide venture capital to a range of enterprises developing veterinary diagnostics, veterinary medicine, information technologies, online platforms and more. The new fund will be independently managed by Digitalis Ventures focusing on both early and growth-stage startups with an ambition to support portfolio companies with differentiated expertise throughout their development while allowing them to maintain their independence, speed, and flexibility. 

“With our second Companion Fund, we are eager to support the next wave of great ideas for advancing animal health at scale," said Geoffrey W. Smith, Founder and Managing Partner of Digitalis Ventures. "Our partnership with Mars makes these advances possible.”

Since its inception, Companion Fund has quickly become one of the world's leading investment funds for early-stage pet care start-ups, with investments in innovative companies such as Smalls, MySimplePetLab and Scratch. Companion Fund II will support even more startups through their growth phases – confirming Mars’ ongoing commitment to support pet care innovators and its long-term partnership with Digitalis Ventures.

Plans are for the Fund to invest in animal health companies based primarily in the United States and Europe. Digitalis Ventures is encouraging founders of early-stage animal health firms seeking venture capital to visit for more information.

Investment Contacts
For Digitalis Ventures:

Media Contacts
For Digitalis Ventures:
Kate Felsen

For Mars:

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Chelsey Quick
Chelsey Quick
- VP Client Success -

We offer built-to-order pet care coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.